Diagnóstico, estratificación del riesgo y tratamiento actual | 09 JUN 19

Embolismo pulmonar agudo

La embolia pulmonar es una causa de consulta frecuente en el departamento de urgencias y requiere un alto índice de sospecha.
18
27
INDICE:  1. Página 1 | 2. Referencias bibliográficas
Referencias bibliográficas

1 Prandoni P , Lensing AW , Prins MH et al . Prevalence of pulmonary embolism among patients hospitalized for syncope . N Engl J Med 2016 ; 375 : 1524 – 31 .

2 Kearon C , Akl EA , Ornelas J et al . Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report . Chest 2016 ; 149 : 315 – 52 .

3 Konstantinides SV , Torbicki A , Agnelli G et al . 2014 ESC guidelines on the diagnosis and management of acute pulmonary embolism . Eur Heart J 2014 ; 35 : 3033 – 69k .

4 Howard L , Barden S , Condliffe R et al . British Thoracic Society guideline for the initial outpatient management of pulmonary embolism (PE) . Thorax 2018 ; 73 ( Suppl 2 ): ii1 – 29 .

5 National Institute for Health and Care Excellence . Venous thromboembolic diseases: the management of venous thromboembolic diseases and the role of thrombophilia testing. Clinical guideline [CG144] . London: NICE , 2015 .

6 Righini M , Le Gal G , Aujesky D et al . Diagnosis of pulmonary embolism by multidetector CT alone or combined with venous ultrasonography

of the leg: a randomised non-inferiority trial . Lancet 2008 ; 371 : 1343 - 52 .

7 Miller WT Jr , Marinari LA , Barbosa E Jr et al . Small pulmonary artery defects are not reliable indicators of pulmonary embolism . Ann Am Thorac Soc 2015 ; 12 : 1022 – 9 .

8 Meyer G , Vicaut E , Danays T et al . Fibrinolysis for patients with intermediate-risk pulmonary embolism . N Engl J Med 2014 ; 370 : 1402 – 11 .

9 Konstantinides SV , Vicaut E , Danays T et al . Impact of thrombolytic therapy on the long-term outcome of intermediate-risk pulmonary embolism . J Am Coll Cardiol 2017 ; 69 : 1536 – 44.

10 Jimenez D , Kopecna D , Tapson V et al . Derivation and validation of multimarker prognostication for normotensive patients with acute symptomatic pulmonary embolism . Am J Respir Crit Care Med 2014 ; 189 : 718 – 26 .

11 Barco S , Vicaut E , Klok FA et al . Improved identification of thrombolysis candidates amongst intermediate-risk pulmonary embolism patients: implications for future trials . Eur Respir J 2018 ; 51 : 1701775 .

12 Chatterjee S , Chakraborty A , Weinberg I et al . Thrombolysis for pulmonary embolism and risk of all-cause mortality, major bleeding, and intracranial hemorrhage: a meta-analysis . JAMA 2014 ; 311 : 2414 – 21 .

13 Dudzinski DM , Piazza G. Multidisciplinary pulmonary embolism response teams . Circulation 2016 ; 133 : 98 – 103 . 14 Tapson VF , Sterling K , Jones N et al . A randomized trial of the optimum duration of acoustic pulse thrombolysis procedure in acute intermediate-risk pulmonary embolism: The OPTALYSE PE trial . JACC Cardiovasc Interv 2018 ; 11 : 1401 – 10 .

15 Wang C , Zhai Z , Yang Y et al . Efficacy and safety of low doce recombinant tissue-type plasminogen activator for the treatment of acute pulmonary thromboembolism: a randomized, multicenter, controlled trial . Chest 2010 ; 137 : 254 – 62 .

16 Jimenez D , Martin-Saborido C , Muriel A et al . Efficacy and safety outcomes of recanalisation procedures in patients with acute symptomatic pulmonary embolism: systematic review and network meta-analysis . Thorax 2018 ; 73 : 464 – 71.

17 Zondag W , Vingerhoets LM , Durian MF et al . Hestia criteria can safely select patients with pulmonary embolism for outpatient treatment irrespective of right ventricular function . J Thromb Haemost 2013 ; 11 : 686 – 92.

18 van der Hulle T , Huisman MV , Klok FA . Meta-analysis of the efficacy and safety of new oral anticoagulants in patients with cancer-associated acute venous thromboembolism: reply . J Thromb Haemost 2014 ; 12 : 2138 – 9 .

19 Mismetti P , Laporte S , Pellerin O et al . Effect of a retrievable inferior vena cava filter plus anticoagulation vs anticoagulation alone on risk of recurrent pulmonary embolism: a randomized clinical trial . JAMA 2015 ; 313:1627 – 35.

20 Khorana AA , Noble S , Lee AYY et al . Role of direct oral anticoagulants in the treatment of cancer-associated venous thromboembolism: guidance from the SSC of the ISTH . J Thromb Haemost 2018 ; 16 : 1891 – 94 .

21 Koc M , Kostrubiec M , Elikowski W et al . Outcome of patients with right heart thrombi: the Right Heart Thrombi European Registry. Eur Respir J 2016 ; 47 : 869 – 75 .

22 Condliffe R , Elliot CA , Hughes RJ et al . Management dilemmas in acute pulmonary embolism . Thorax 2014 ; 69 : 174 – 80 .

23 Hunter R , Lewis S , Noble S et al . ‘ Post-thrombotic panic syndrome’: A thematic analysis of the experience of venous thromboembolism . Br J Health Psychol 2017 ; 22 : 8 – 25.

 

Comentarios

Usted debe ingresar al sitio con su cuenta de usuario IntraMed para ver los comentarios de sus colegas o para expresar su opinión. Si ya tiene una cuenta IntraMed o desea registrase, ingrese aquí